GlucoStabilizer Reduces Hypoglycemia

GlucoStabilizer Manages Dosing, Stabilizes Glucose Levels and Reduces the Risk of Hypoglycemia by:

  • Programming safety features for hypoglycemia awareness

  • Taking into consideration an individual patient’s sensitivity to insulin

  • Decreasing the time required to achieve and maintain blood glucose targets

  • Eliminating rebound hypoglycemia with patient specific recommendations for 50% dextrose

Distribution of Glucose Readings:

In this analysis, which included 192,956 ICU glucose readings and 2,509 patients using GlucoStabilizer, 87.9% fell within a range of 71-150mg/dL with a hypoglycemic rate of just 0.13%.

 

Source: Clarian Health System, Indianapolis, IN

 

See Comparisons;

 


Results in the Surgical ICU:

In this before and after chart, Tufts NEMC reduced their average patient glucose results in their ICU by more than 23%, with less hypoglycemia, following the implementation of GlucoStabilizer.

Source: Tufts New England Medical Center, Boston

 

 


Achieving Glucose Control:

In another before and after analysis, 3 times as many patients stayed within their range after reaching a target of 80-110 mg/dL.

Source: Battle Creek Health System, MI

News  I  Contact Us  I  Home

 © 2011 MAS. All rights reserved.  GlucoStabilizer is a trademark of MAS.